JULIA GODFREY: Open Payments
NPI 1285913228 · NORTHAMPTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 20 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $598
Food & beverage: $598
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 13 | $450 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $26 |
| Verona Pharma, Inc. | 1 | $21 |
| Baxter Healthcare | 1 | $19 |
| La Jolla Pharmaceutical Company | 1 | $18 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
Products named: Remodulin, Orenitram, Tyvaso, LIVTENCITY, EMBLAVEO, Ohtuvayre, Hillrom - Monarch Airway Clearance System, GIAPREZA.
Industry payments across MA — which companies pay providers there.
